Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance

  • Jeffrey F. Krane
  • Ritu Nayar
  • Andrew A. Renshaw


The classification of “indeterminate” lesions (those not clearly benign or malignant) in thyroid cytopathology has long been a source of confusion for both pathologists and clinicians. There has been much variation in how cytopathologists perceive, interpret, and report such aspirates, especially when the uncertainty relates to follicular lesions. Clinicians have tended to lump interpretations like “follicular lesion,” “atypical,” “follicular neoplasm,” “indeterminate for neoplasia,” and “suspicious for malignancy” into a single “indeterminate for malignancy” category for conceptual and even management purposes. Follow up studies, however, have shown significantly different clinical outcomes for distinct subcategories within the generic indeterminate category. For this reason, it is advisable to define and distinguish categories with distinct risk associations for malignancy, like “Suspicious for follicular neoplasm” versus “Suspicious for malignancy (e.g., papillary carcinoma).” In a minority of cases, the cytologic and/or architectural atypia encountered is of uncertain significance: it is of an insufficient degree to qualify for any of the suspicious categories. Such cases have a lower risk of malignancy and deserve to be separated from the suspicious categories.


Papillary Carcinoma Follicular Cell Multinodular Goiter Follicular Neoplasm Undetermined Significance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16(2):109-142.CrossRefPubMedGoogle Scholar
  2. 2.
    Wang HH. Reporting thyroid fine-needle aspiration: literature review and a proposal. Diagn Cytopathol. 2006;34(1):67-76.CrossRefPubMedGoogle Scholar
  3. 3.
    Gharib H, Goellner JR, Johnson DA. Fine-needle aspiration cytology of the thyroid: a 12-year experience with 11, 000 biopsies. Clin Lab Med. 1993;13:699-709.PubMedGoogle Scholar
  4. 4.
    Yassa L, Cibas ES, Benson CB, et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer. 2007;111(6):508-516.CrossRefPubMedGoogle Scholar
  5. 5.
    Nayar R, Ivanovic M. The indeterminate thyroid FNA: Experience from an academic center using terminology similar to that proposed in the 2007 NCI Thyroid Fine Needed Aspiration State of the Science Conference. Cancer Cytopathol 2009;117:195–202.Google Scholar
  6. 6.
    Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Int Med. 1993;118:282-289.PubMedGoogle Scholar
  7. 7.
    Baloch ZW, LiVolsi VA, Asa SL, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36(6):425-437.CrossRefPubMedGoogle Scholar
  8. 8.
    Yang J, Schnadig V, Logrono R, Wasserman PG. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007;111(5):306-315.CrossRefPubMedGoogle Scholar
  9. 9.
    Poller DN, Ibrahim AK, Cummings MH, et al. Fine-needle aspiration of the thyroid; the importance of an indeterminate diagnostic category. Cancer (Cancer Cytopathol). 2000;90:239-244.Google Scholar
  10. 10.
    Renshaw AA. Accuracy of thyroid fine-needle aspiration using receiver operator ­characteristic curves. Am J Clin Pathol. 2001;116:477-482.CrossRefPubMedGoogle Scholar
  11. 11.
    Renshaw AA. Focal features of papillary carcinoma of the thyroid in fine-needle aspiration material are strongly associated with papillary carcinoma at resection. Am J Clin Pathol. 2002;118(2):208-210.CrossRefPubMedGoogle Scholar
  12. 12.
    Weber D, Brainard J, Chen L. Atypical epithelial cells, cannot exclude papillary carcinoma, in fine needle aspiration of the thyroid. Acta Cytol. 2008;52(3):320-324.PubMedGoogle Scholar
  13. 13.
    Logani S, Gupta PK, LiVolsi VA, et al. Thyroid nodules with FNA cytology suspicious for follicular variant of papillary thyroid carcinoma: follow-up and management. Diagn Cytopathol. 2000;23(6):380-385.CrossRefPubMedGoogle Scholar
  14. 14.
    Faquin WC, Cibas ES, Renshaw AA. “Atypical” cells in fine-needle aspiration biopsy specimens of benign thyroid cysts. Cancer. 2005;105(2):71-79.CrossRefPubMedGoogle Scholar
  15. 15.
    Smejkal V, Smejkalova E, Rosa M, et al. Cytologic changes simulating malignancy in thyrotoxic goiters treated with carbimazole. Acta Cytol. 1985;29:173-178.PubMedGoogle Scholar
  16. 16.
    Granter SR, Cibas ES. Cytologic findings in thyroid nodules after 131iodine treatment of hyperthyroidism. Am J Clin Pathol. 1997;107:20-25.PubMedGoogle Scholar
  17. 17.
    Centeno BA, Szyfelbein WM, Daniels GH, et al. Fine-needle aspiration biopsy of the thyroid gland in patients with prior Graves’ disease treated with radioactive iodine: morphologic findings and potential pitfalls. Acta Cytol. 1996;40:1189-1197.PubMedGoogle Scholar
  18. 18.
    Layfield LJ, Abrams J, Cochand-Priollet B, et al. Post-thyroid FNA testing and treatment options: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36(6):442-448.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Jeffrey F. Krane
    • 1
  • Ritu Nayar
    • 2
  • Andrew A. Renshaw
    • 3
  1. 1.Department of PathologyBrigham and Women’s Hospital and Harvard Medical SchoolBostonUSA
  2. 2.Department of PathologyNorthwestern University, Feinberg School of MedicineChicagoUSA
  3. 3.Department of PathologyBaptist Hospital of MiamiMiamiUSA

Personalised recommendations